The Future of Genetic Medicine & RNA Editing

Session details:

Dr. Erik Ingelsson, Chief Scientific Officer of Wave Life Sciences, will delve into recent clinical milestones in genetic medicine (including the first-ever demonstration of RNA editing in humans), the pathway from discovery to clinical implementation, strategies for leveraging human genetics to de-risk drug development, and other advancements in oligonucleotides (including the latest in siRNA). The session will also explore AI’s role in improving precision and target selection.